Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single Arm, Open-label Multicenter Phase II Trial of Temsirolimus in Patients With Relapsed/Recurrent Squamous Cell Cancer of the Head and Neck (HNSCC)

NCT01172769 is registered in ClinicalTrials.gov with Hannover Medical School as lead sponsor.

NCT NCT01172769
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01172769 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single Arm, Open-label Multicenter Phase II Trial of Temsirolimus in Patients With Relapsed/Recurrent Squamous Cell Cancer of the Head and Neck (HNSCC)
Lead sponsor
Hannover Medical School
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2010
Completion date
March 31, 2012
Enrollment
42 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck squamous cell carcinoma